Inactive Instrument

William Demant Holding Share Price Nasdaq Copenhagen

Equities

DK0060738599

Medical Equipment, Supplies & Distribution

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 23.26B 3.38B 282B Sales 2025 * 25.05B 3.63B 303B Capitalization 70.36B 10.21B 852B
Net income 2024 * 3.04B 442M 36.86B Net income 2025 * 3.51B 509M 42.47B EV / Sales 2024 * 3.6 x
Net Debt 2024 * 13.44B 1.95B 163B Net Debt 2025 * 13.38B 1.94B 162B EV / Sales 2025 * 3.34 x
P/E ratio 2024 *
23.1 x
P/E ratio 2025 *
19.6 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 39.27%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Director of Finance/CFO 51 01/15/01
Director/Board Member 66 01/92/01
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman 58 01/08/01
Director/Board Member 66 01/92/01
Director/Board Member 57 01/21/01
More insiders
Demant A/S is the world's 2nd leading producer of audio products. Net sales (excluding activities held for sale) break down by family of products as follows: - tailor-made hearing aids (44.7%): hearing aid and audiphones sold under the Oticon, Bernafon, Philips and Sonic brands; - hearing care products (40.5%): sold in clinics under the brands Audika, HearingLife, Hidden Hearing and Acústica Médica; - diagnostic products (1116%): audiometers sold under the brands Maico, Interacoustics, amplivox, gsi, MedRx and audioscan; - business communication solutions (3.7%). Net sales (excluding activities held for sale) are distributed geographically as follows: Denmark (1.2%), France (9.9%), Europe (29.7%), the United States (34.1%), North America (7%), Asia (10.4%), Pacific (4.9%) and other (2.8%).
Calendar
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW